Evaluation of longevity enhancing compounds against transactive response DNA-binding protein-43 neuronal toxicity.
about
Using C. elegans to discover therapeutic compounds for ageing-associated neurodegenerative diseasesHeritable transmission of stress resistance by high dietary glucose in Caenorhabditis elegansCaenorhabditis elegans dnj-14, the orthologue of the DNAJC5 gene mutated in adult onset neuronal ceroid lipofuscinosis, provides a new platform for neuroprotective drug screening and identifies a SIR-2.1-independent action of resveratrol.Ethosuximide ameliorates neurodegenerative disease phenotypes by modulating DAF-16/FOXO target gene expressionEthosuximide Induces Hippocampal Neurogenesis and Reverses Cognitive Deficits in an Amyloid-β Toxin-induced Alzheimer Rat Model via the Phosphatidylinositol 3-Kinase (PI3K)/Akt/Wnt/β-Catenin PathwayConserved pharmacological rescue of hereditary spastic paraplegia-related phenotypes across model organisms.Worming forward: amyotrophic lateral sclerosis toxicity mechanisms and genetic interactions in Caenorhabditis elegans.Extracellular dopamine and alterations on dopamine transporter are related to reserpine toxicity in Caenorhabditis elegans.Neurodegeneration in C. elegans models of ALS requires TIR-1/Sarm1 immune pathway activation in neurons.α-Methyl-α-phenylsuccinimide ameliorates neurodegeneration in a C. elegans model of TDP-43 proteinopathyA Caenorhabditis elegans assay of seizure-like activity optimised for identifying antiepileptic drugs and their mechanisms of action
P2860
Q26776093-2C1C59F2-7CBA-45EC-9184-2544557A6528Q27315866-050317BD-75D7-4214-8FA6-22BBF3E38216Q30594778-BE92CE9E-23CC-4371-9B88-EE9807ABF720Q30666205-C67EBC1F-973B-491F-B6B9-B5D2B0ECD1E2Q36301359-A969560F-C1A4-4774-BEEA-864E6619F5DFQ36608852-64DD193C-4F86-478C-9873-EF8CE858DCC0Q38214677-5AF97FAE-ED67-483E-9D9F-9F0B107E38B1Q42471356-5CE82F24-C924-4E4D-9387-F068A1E07581Q48177436-539DF22B-A976-492B-B31C-DA78A4276876Q57143998-C15C5ECC-AF62-4E7D-9A76-96FB657BB5DAQ58702262-B18E936D-5C01-4BD5-8258-ABBE54FCBAD1
P2860
Evaluation of longevity enhancing compounds against transactive response DNA-binding protein-43 neuronal toxicity.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Evaluation of longevity enhanc ...... protein-43 neuronal toxicity.
@en
Evaluation of longevity enhanc ...... protein-43 neuronal toxicity.
@nl
type
label
Evaluation of longevity enhanc ...... protein-43 neuronal toxicity.
@en
Evaluation of longevity enhanc ...... protein-43 neuronal toxicity.
@nl
prefLabel
Evaluation of longevity enhanc ...... protein-43 neuronal toxicity.
@en
Evaluation of longevity enhanc ...... protein-43 neuronal toxicity.
@nl
P1476
Evaluation of longevity enhanc ...... g protein-43 neuronal toxicity
@en
P2093
Carl Julien
P304
P356
10.1016/J.NEUROBIOLAGING.2013.03.014
P577
2013-04-13T00:00:00Z